Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131


Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.

Gomes JA, Campi-Azevedo AC, Teixeira-Carvalho A, Silveira-Lemos D, Vitelli-Avelar D, Sathler-Avelar R, Peruhype-Magalhães V, Silvestre KF, Batista MA, Schachnik NC, Correa-Oliveira R, Eloi-Santos S, Martins-Filho OA.

Immunobiology. 2012 Oct;217(10):1005-16. doi: 10.1016/j.imbio.2012.01.014. Epub 2012 Jan 20.


Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.

Gomes JA, Molica AM, Keesen TS, Morato MJ, de Araujo FF, Fares RC, Fiuza JA, Chaves AT, Pinheiro V, Nunes Mdo C, Correa-Oliveira R, da Costa Rocha MO.

Hum Immunol. 2014 Jan;75(1):20-8. doi: 10.1016/j.humimm.2013.09.009. Epub 2013 Sep 24.


Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.

Vitelli-Avelar DM, Sathler-Avelar R, Teixeira-Carvalho A, Pinto Dias JC, Gontijo ED, Faria AM, Elói-Santos SM, Martins-Filho OA.

Scand J Immunol. 2008 Nov;68(5):516-25. doi: 10.1111/j.1365-3083.2008.02167.x. Epub 2008 Sep 18.


Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events.

Campi-Azevedo AC, Gomes JA, Teixeira-Carvalho A, Silveira-Lemos D, Vitelli-Avelar DM, Sathler-Avelar R, Peruhype-Magalhães V, Béla SR, Silvestre KF, Batista MA, Schachnik NC, Correa-Oliveira R, Eloi-Santos SM, Martins-Filho OA.

Immunobiology. 2015 May;220(5):564-74. doi: 10.1016/j.imbio.2014.12.006. Epub 2015 Jan 8.


Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens.

Sathler-Avelar R, Vitelli-Avelar DM, Elói-Santos SM, Gontijo ED, Teixeira-Carvalho A, Martins-Filho OA.

BMC Infect Dis. 2012 May 24;12:123. doi: 10.1186/1471-2334-12-123.


Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi.

Lorena VM, Lorena IM, Braz SC, Melo AS, Melo MF, Melo MG, Silva ED, Ferreira AG, Morais CN, Costa VM, Correa-Oliveira R, Gomes YM.

Scand J Immunol. 2010 Dec;72(6):529-39. doi: 10.1111/j.1365-3083.2010.02462.x.


Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.

Sathler-Avelar R, Vitelli-Avelar DM, Massara RL, Borges JD, Lana M, Teixeira-Carvalho A, Dias JC, Elói-Santos SM, Martins-Filho OA.

Scand J Immunol. 2006 Nov;64(5):554-63.


Systems Biology Reveals Relevant Gaps in Fc-γR Expression, Impaired Regulatory Cytokine Microenvironment Interfaced With Anti-Trypanosoma cruzi IgG Reactivity in Cardiac Chagas Disease Patients.

Gomes JAS, de Araújo FF, Vitelli-Avelar DM, Sathler-Avelar R, Lage PS, Wendling APB, do Vale INPC, Dias JCP, Elói-Santos SM, Teixeira-Carvalho A, Martins-Filho OA.

Front Microbiol. 2018 Jul 30;9:1608. doi: 10.3389/fmicb.2018.01608. eCollection 2018.


Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.

Medeiros NI, Fares RC, Franco EP, Sousa GR, Mattos RT, Chaves AT, Nunes MD, Dutra WO, Correa-Oliveira R, Rocha MO, Gomes JA.

PLoS Negl Trop Dis. 2017 Jan 24;11(1):e0005284. doi: 10.1371/journal.pntd.0005284. eCollection 2017 Jan.


Specific activation of CD4- CD8- double-negative T cells by Trypanosoma cruzi-derived glycolipids induces a proinflammatory profile associated with cardiomyopathy in Chagas patients.

Passos LSA, Magalhães LMD, Soares RP, Marques AF, Nunes MDCP, Gollob KJ, Dutra WO.

Clin Exp Immunol. 2017 Oct;190(1):122-132. doi: 10.1111/cei.12992. Epub 2017 Jul 3.


Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.

Nunes DF, Guedes PM, Andrade Cde M, Câmara AC, Chiari E, Galvão LM.

Trop Med Int Health. 2013 Oct;18(10):1180-92. doi: 10.1111/tmi.12169. Epub 2013 Aug 1.


Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.

de Araújo FF, Corrêa-Oliveira R, Rocha MO, Chaves AT, Fiuza JA, Fares RC, Ferreira KS, Nunes MC, Keesen TS, Damasio MP, Teixeira-Carvalho A, Gomes JA.

Immunobiology. 2012 Aug;217(8):768-77. doi: 10.1016/j.imbio.2012.04.008. Epub 2012 May 9.


In-house ELISA method to analyze anti-Trypanosoma cruzi IgG reactivity for differential diagnosis and evaluation of Chagas disease morbidity.

Santos Lda S, Torres RM, Machado-de-Assis GF, Bahia MT, Martins HR, Teixeira-Carvalho A, Coelho-Dos-Reis JG, Albajar-Viñas P, Martins-Filho OA, Lana Md.

Rev Soc Bras Med Trop. 2012 Feb;45(1):35-44.


Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients.

Verçosa AF, Lorena VM, Carvalho CL, Melo MF, Cavalcanti MG, Silva ED, Ferreira AG, Pereira VR, Souza WV, Gomes YM.

J Clin Lab Anal. 2007;21(5):271-6.


Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease.

Morgan J, Dias JC, Gontijo ED, Bahia-Oliveira L, Correa-Oliveira R, Colley DG, Powell MR.

Am J Trop Med Hyg. 1996 Oct;55(4):355-9.


Non-conventional flow cytometry approaches to detect anti-Trypanosoma cruzi immunoglobulin G in the clinical laboratory.

Vitelli-Avelar DM, Sathler-Avelar R, Wendling AP, Rocha RD, Teixeira-Carvalho A, Martins NE, Dias JC, Rassi A, Luquetti AO, Elói-Santos SM, Martins-Filho OA.

J Immunol Methods. 2007 Jan 10;318(1-2):102-12. Epub 2006 Nov 13.


Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi.

Lorena VM, Verçosa AF, Machado RC, Moitinho-Silva L, Cavalcanti MG, Silva ED, Ferreira AG, Correa-Oliveira R, Pereira VR, Gomes YM.

J Clin Lab Anal. 2008;22(2):91-8. doi: 10.1002/jcla.20209.


Supplemental Content

Support Center